24 Del. C. § 2566: Independent prescriptive authority [For application of this section, see 85 Del. Laws, c. 418, § 6].

(a) A pharmacist licensed under this chapter may exercise independent prescriptive authority as follows:

(1) For over-the-counter products.

(2) In accordance with a collaborative pharmacy practice agreement.

(3) For opioid antagonists as permitted under Chapter 30G of Title 16.

(4) Drug categories or devices, except for controlled substances, that are prescribed in accordance with the product’s U.S. Food and Drug Administration-approved labeling and that are limited to conditions that meet any of the following criteria:

a. Do not require a new diagnosis.

b. Are minor and generally self-limiting.

c. Have a test that is used to guide diagnosis or clinical decision-making, including any established screening procedures that can be safely performed by a pharmacist and any tests waived under the federal Clinical Laboratory Improvement Amendments of 1988 [42 U.S.C. § 263a], as amended, or the federal rules adopted under the federal Clinical Laboratory Improvement Amendments of 1988 [42 U.S.C. § 263a], as amended.

(b) A pharmacist licensed under this chapter may not prescribe controlled substances except as provided for in § 2568 of this title regarding medications for opioid use disorder treatment.